The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma. - Hsu YC; Wu MC; Chen CH; Lee YT; Lin CI; Chou HC; Lee HS; Wang LF; Sheu JC; Weng MT (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026)